Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells

Area of Science:

• Cell Biology
• Genomics
• Drug Discovery

Background:

• Small airway epithelial cells (SAECs) are vital for studying lung diseases and drug development.
• Traditional transfection methods are inefficient for SAECs, hindering genetic studies.
• CRISPR/Cas9 gene editing via ribonucleoprotein (RNP) electroporation is a common alternative.

Purpose of the Study:

• To establish a scalable and automated CRISPR nuclease (CRISPRn) screening workflow for SAECs.
• To facilitate target identification and validation in lung disease research.
• To enable combination with various disease-specific assays.

Main Methods:

• Development of a robust, scalable, and automated arrayed CRISPRn screening workflow.
• Utilized ribonucleoprotein (RNP) electroporation for efficient gene editing in SAECs.
• Integrated the workflow with diverse disease-specific endpoint assays.

Main Results:

• Successfully established an automated CRISPRn screening workflow for SAECs.
• Demonstrated the workflow's robustness and scalability.
• Showcased the compatibility with multiple disease-specific assays.

Conclusions:

• The developed workflow provides an efficient method for gene editing in SAECs.
• This advancement supports target identification and validation in lung disease drug discovery.
• The automated system offers a versatile platform for future research.